Id-1 expression in androgen-dependent prostate cancer is negatively regulated by androgen through androgen receptor. 2009

Bin Xu, and Yinghao Sun, and Gusheng Tang, and Chuanliang Xu, and Linhui Wang, and Yuxi Zhang, and Jiatao Ji
Department of Urology, Changhai Hospital, 174 Changhai Road, Shanghai 200433, China.

This study discovered that Id-1 expression in androgen-dependent prostate cancer decreased immediately after androgen deprivation but increased after longer androgen deprivation both in vivo and in vitro. Id-1 expression in androgen-independent LNCaP cells was about 6 fold as that in their parental cells. As was the case with LNCaP cells, when androgen receptor (AR) was introduced into AR-negative PC-3 cells, dihydrotestosterone inhibited while flutamide increased Id-1 expression. Thus, Id-1 expression in androgen-dependent prostate cancer was negatively regulated by androgen in a receptor-dependent way. The re-increased Id-1 might partially contribute to the emergence of androgen-independent prostate cancer after longer androgen deprivation therapy.

UI MeSH Term Description Entries
D008297 Male Males
D009376 Neoplasms, Hormone-Dependent Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment. Hormone-Dependent Neoplasms,Hormone Dependent Neoplasms,Hormone-Dependent Neoplasm,Neoplasm, Hormone-Dependent,Neoplasms, Hormone Dependent
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011944 Receptors, Androgen Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA. Androgen Receptors,5 alpha-Dihydrotestosterone Receptor,Androgen Receptor,Dihydrotestosterone Receptors,Receptor, Testosterone,Receptors, Androgens,Receptors, Dihydrotestosterone,Receptors, Stanolone,Stanolone Receptor,Testosterone Receptor,5 alpha Dihydrotestosterone Receptor,Androgens Receptors,Receptor, 5 alpha-Dihydrotestosterone,Receptor, Androgen,Receptor, Stanolone,Stanolone Receptors,alpha-Dihydrotestosterone Receptor, 5
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000728 Androgens Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013196 Dihydrotestosterone A potent androgenic metabolite of TESTOSTERONE. It is produced by the action of the enzyme 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. 5 alpha-Dihydrotestosterone,Androstanolone,Stanolone,17 beta-Hydroxy-5 beta-Androstan-3-One,17beta-Hydroxy-5alpha-Androstan-3-One,5 beta-Dihydrotestosterone,5-alpha Dihydrotestosterone,5-alpha-DHT,Anaprotin,Andractim,Dihydroepitestosterone,Gelovit,17 beta Hydroxy 5 beta Androstan 3 One,17beta Hydroxy 5alpha Androstan 3 One,5 alpha DHT,5 alpha Dihydrotestosterone,5 beta Dihydrotestosterone,Dihydrotestosterone, 5-alpha,beta-Hydroxy-5 beta-Androstan-3-One, 17
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D051798 Inhibitor of Differentiation Protein 1 A HELIX-LOOP-HELIX MOTIF-containing negative regulator of BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS that blocks activation of CYCLIN-DEPENDENT KINASE INHIBITOR P16 and is de-regulated in a variety of NEOPLASMS. DNA-Binding Protein Inhibitor ID1,Inhibitor of DNA Binding Protein 1,DNA Binding Protein Inhibitor ID1

Related Publications

Bin Xu, and Yinghao Sun, and Gusheng Tang, and Chuanliang Xu, and Linhui Wang, and Yuxi Zhang, and Jiatao Ji
December 2007, Neoplasia (New York, N.Y.),
Bin Xu, and Yinghao Sun, and Gusheng Tang, and Chuanliang Xu, and Linhui Wang, and Yuxi Zhang, and Jiatao Ji
February 2015, International journal of cancer,
Bin Xu, and Yinghao Sun, and Gusheng Tang, and Chuanliang Xu, and Linhui Wang, and Yuxi Zhang, and Jiatao Ji
December 1998, Cancer research,
Bin Xu, and Yinghao Sun, and Gusheng Tang, and Chuanliang Xu, and Linhui Wang, and Yuxi Zhang, and Jiatao Ji
September 2007, Endocrine-related cancer,
Bin Xu, and Yinghao Sun, and Gusheng Tang, and Chuanliang Xu, and Linhui Wang, and Yuxi Zhang, and Jiatao Ji
October 2011, Cancer cell,
Bin Xu, and Yinghao Sun, and Gusheng Tang, and Chuanliang Xu, and Linhui Wang, and Yuxi Zhang, and Jiatao Ji
January 2004, Cancer research,
Bin Xu, and Yinghao Sun, and Gusheng Tang, and Chuanliang Xu, and Linhui Wang, and Yuxi Zhang, and Jiatao Ji
April 2004, Carcinogenesis,
Bin Xu, and Yinghao Sun, and Gusheng Tang, and Chuanliang Xu, and Linhui Wang, and Yuxi Zhang, and Jiatao Ji
June 2010, International journal of cancer,
Bin Xu, and Yinghao Sun, and Gusheng Tang, and Chuanliang Xu, and Linhui Wang, and Yuxi Zhang, and Jiatao Ji
January 2004, Reproductive biology and endocrinology : RB&E,
Bin Xu, and Yinghao Sun, and Gusheng Tang, and Chuanliang Xu, and Linhui Wang, and Yuxi Zhang, and Jiatao Ji
March 2013, Oncogene,
Copied contents to your clipboard!